From: Influence of extracorporeal membrane oxygenation on the pharmacokinetics of ceftolozane/tazobactam: an ex vivo and in vivo study
Parameter
Model mean
RSE (%)
Fixed effects
Cl (l/h)
24.2
7.86
βECMO/Cl
− 0.304
35.2
V1 (l)
8.71
16.6
Q (l/h)
7.19
26.4
V2 (l)
6.37
14.1
BSV (%)
Cl
11.3
44.9
V1
32.4
38.7
Q
31.9
44.5
V2
15.1
Residual variability (%)
19.9
10.8